What is the growth forecast for the Enteral Nutrition market?

The Enteral Nutrition market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Parenteral Nutrition market?

Key drivers include increasing demand for nutrition therapy and rising prevalence of malnutrition.

What are the challenges facing the Enteral Nutrition and Parenteral Nutrition market?

Challenges include high costs, limited reimbursement, and product recalls.

Which regions are leaders in the Enteral Nutrition market?

North America and Europe are regional leaders due to high healthcare expenditure.

Who are the top companies in the Parenteral Nutrition market?

Top companies include Baxter, B. Braun, and Fresenius Kabi.

What future opportunities exist in the Enteral Nutrition and Parenteral Nutrition market?

Future opportunities include emerging markets and innovative product developments.

How will technology impact the Enteral Nutrition and Parenteral Nutrition market?

Technology will enhance patient outcomes through personalized nutrition and telehealth services.

What is the regulatory landscape for the Enteral Nutrition and Parenteral Nutrition market?

The regulatory landscape is governed by FDA and EU guidelines ensuring product safety.

What Is the Global Enteral Nutrition and Parenteral Nutrition Market Worth in 2026?

Enteral Nutrition and Parenteral Nutrition by Application (Hospital Clinic, Pharmacy, Others), by Types (Oral/Tube Feeding, Intravenous Injection), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Enteral Nutrition and Parenteral Nutrition Market Overview

The Enteral Nutrition and Parenteral Nutrition market refers to the industry that provides nutritional support to patients who are unable to receive nutrition through the normal digestive process. As the global population ages and the prevalence of chronic diseases increases, the Enteral Nutrition and Parenteral Nutrition market size is expected to experience significant growth, driven by the rising demand for nutrition therapy and clinical nutrition. The growth outlook for the Enteral Nutrition and Parenteral Nutrition market is positive, with a market forecast that indicates a compound annual growth rate (CAGR) of around 7-8% from 2026 to 2033, driven by macro drivers such as the increasing incidence of malnutrition, the growing awareness of the importance of nutrition therapy, and the rising demand for home care services. The current Enteral Nutrition and Parenteral Nutrition market size is estimated to be around $14.5 billion in 2025.

Loading chart…

The Enteral Nutrition and Parenteral Nutrition market is shaped by several key forces, including technology shifts in the development of new nutritional products and delivery systems, regulations that govern the use of nutritional products in different regions, and consumer behavior that is driving the demand for home care services. The largest region in the Enteral Nutrition and Parenteral Nutrition market is North America, while the fastest-growing region is Asia-Pacific. The industry expansion is expected to be driven by the increasing demand for nutritional products and services in emerging markets, as well as the growing awareness of the importance of nutrition therapy in the prevention and treatment of chronic diseases.

Report Overview

Report Attribute	Details
Market size value in 2025	12.00 billion
Revenue forecast in 2033	21.88 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; B. Braun; Baxter; BBCA Pharmaceutical; Biokin Pharmaceutical; China Meheco Kangli; Cisen; Danone; Fresenius Kabi; Grand Life Sciences; Haisco Pharmaceutical Group; JW Pharmaceutical; Kelun Pharma; King York; Lionco Pharmaceutical; Lummy; Medisan; Medtrition; Nestlé S.A.; Otsuka Pharmaceutical; Pfizer; Teva Pharmaceutical; Xi'an Libang Pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Enteral Nutrition and Parenteral Nutrition market is witnessing significant growth, driven by various factors. The Enteral Nutrition and Parenteral Nutrition market size is expected to expand substantially during the forecast period, with a promising growth forecast.

Growth Drivers2 items

Increasing prevalence of chronic diseases, such as cancer, diabetes, and gastrointestinal disorders, is driving the demand for Enteral Nutrition and Parenteral Nutrition products, ultimately contributing to the growth of the Enteral Nutrition and Parenteral Nutrition market.

Advances in medical technology and the development of innovative nutritional products are enhancing patient outcomes, thereby boosting the adoption of Enteral Nutrition and Parenteral Nutrition solutions and influencing the Enteral Nutrition and Parenteral Nutrition market size.

Restraints2 items

Stringent regulatory requirements and high production costs are limiting the entry of new players in the Enteral Nutrition and Parenteral Nutrition market, which may hinder the growth forecast.

Product recalls and safety concerns related to Enteral Nutrition and Parenteral Nutrition products can erode consumer trust, negatively impacting the overall Enteral Nutrition and Parenteral Nutrition market size.

Opportunities2 items

The rising demand for home-based Enteral Nutrition and Parenteral Nutrition services is creating new opportunities for market players to develop innovative, patient-centric solutions and drive growth in the Enteral Nutrition and Parenteral Nutrition market.

The growing awareness about the importance of nutrition therapy in healthcare is expected to fuel the adoption of Enteral Nutrition and Parenteral Nutrition products, contributing to a positive growth forecast for the Enteral Nutrition and Parenteral Nutrition market.

Challenges2 items

Ensuring the quality and safety of Enteral Nutrition and Parenteral Nutrition products while maintaining competitive pricing is a significant challenge faced by market players, which can impact the Enteral Nutrition and Parenteral Nutrition market size.

The complex reimbursement landscape for Enteral Nutrition and Parenteral Nutrition services can hinder patient access to these therapies, affecting the growth forecast of the Enteral Nutrition and Parenteral Nutrition market.

Market Segmentation

Loading chart…

The Enteral Nutrition market can be segmented based on application and types. The application segment includes various subtypes such as [object Object],[object Object], which contribute to the overall Enteral Nutrition market size. The types segment also comprises subtypes, including [object Object],[object Object], which play a crucial role in shaping the market. Understanding the Enteral Nutrition and Parenteral Nutrition segmentation is essential for industry players to devise effective strategies. The application segment is further divided into subcategories, which are critical in determining the market size.

The Parenteral Nutrition market is also segmented based on application and types. The application segment encompasses various subtypes, such as [object Object],[object Object], which are vital in determining the market size. The types segment includes subtypes, including [object Object],[object Object], which significantly contribute to the overall Parenteral Nutrition market. Analyzing the Enteral Nutrition and Parenteral Nutrition segmentation is crucial for industry stakeholders to gain insights into the market taxonomy. The types segment is further categorized into subtypes, which are essential in understanding the market dynamics.

Enteral Nutrition and Parenteral Nutrition Segmentation Breakdown7 items

Application

Hospital Clinic

Pharmacy

Others

Types

Oral/Tube Feeding

Intravenous Injection

Regional Insights

Loading chart…

The Enteral Nutrition and Parenteral Nutrition market growth is expected to vary across regions, with the largest share held by North America, accounting for approximately 35% of the global market. The fastest-growing region is anticipated to be the Asia Pacific, driven by increasing adoption of Enteral Nutrition and Parenteral Nutrition, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: North America, driven by a mature ecosystem, high demographics awareness, and established infrastructure; Europe, fueled by adoption of home-based Enteral Nutrition and Parenteral Nutrition, policies supporting healthcare access, and a strong investment landscape; Asia Pacific, characterized by a rapidly expanding ecosystem, increasing adoption of Enteral Nutrition and Parenteral Nutrition, and significant investments in healthcare; Latin America, influenced by growing demographics and infrastructure development; and Middle East & Africa, driven by policies supporting healthcare access and a developing ecosystem.

The regional forecast indicates a shift towards the Asia Pacific region, with an expected compound annual growth rate (CAGR) of 8-10% over the next five years. This growth is driven by the increasing adoption of Enteral Nutrition and Parenteral Nutrition, particularly in countries such as China and Japan, and the expanding ecosystem of healthcare providers and manufacturers.

Competitive Landscape

The Enteral Nutrition and Parenteral Nutrition market exhibits a moderately consolidated structure, with a mix of global players and local/regional companies competing on various fronts. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Enteral Nutrition and Parenteral Nutrition competitive landscape is characterized by high competition, with companies employing different strategies to differentiate themselves and gain market share.

Common strategies among key players include M&A, partnerships, product launches, expansion, R&D, and localization. Companies seek to differentiate themselves through technology, service model, channel strength, customization, and cost advantages. However, they face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies must focus on strategic initiatives that drive growth and profitability.

Abbott: regional expansion

B. Braun: premium pricing

Baxter: innovation pipeline

Fresenius Kabi: local manufacturing

Nestlé S.A.: OEM tie-ups

Pfizer: vertical integration

Key Enteral Nutrition and Parenteral Nutrition Companies23 items

Abbott

B. Braun

Baxter

BBCA Pharmaceutical

Biokin Pharmaceutical

China Meheco Kangli

Cisen

Danone

Fresenius Kabi

Grand Life Sciences

Haisco Pharmaceutical Group

JW Pharmaceutical

Kelun Pharma

King York

Lionco Pharmaceutical

Lummy

Medisan

Medtrition

Nestlé S.A.

Otsuka Pharmaceutical

Pfizer

Teva Pharmaceutical

Xi'an Libang Pharmaceutical

Market Ecosystem

The Enteral Nutrition and Parenteral Nutrition ecosystem encompasses a complex network of participants, from upstream technology providers and suppliers to downstream channels and end users. This ecosystem can be broadly segmented into three stages: upstream, where raw materials and components are sourced; midstream, where these inputs are integrated into final products; and downstream, where products are distributed and consumed. Value is created and captured at each stage, from the development of novel nutritional formulations to the delivery of life-sustaining therapies to patients.

Raw material suppliers — provide nutritional components

OEMs/manufacturers — produce enteral and parenteral nutrition products

Distributors/channel partners — deliver products to healthcare facilities

Service providers/after-sales — offer support and maintenance services

End users/buyers — healthcare providers and patients

Regulators/standards bodies — establish safety and efficacy standards

Data/analytics providers — provide insights on nutrition therapy outcomes

In the Enteral Nutrition and Parenteral Nutrition ecosystem, control points are largely influenced by regulators and standards bodies, who dictate the safety and efficacy requirements for nutritional products. Dependency risks arise from input constraints, such as the availability of raw materials, and from standards and approvals, which can vary by region. Switching costs are also a consideration, as healthcare providers may be invested in specific product lines or have established partnerships with certain manufacturers. As the ecosystem differs by region, with diverse regulatory environments and healthcare infrastructure, participants must navigate these complexities to ensure seamless delivery of enteral and parenteral nutrition therapies to patients, necessitating a thorough value chain analysis.

Recent Industry Insights

The Enteral Nutrition and Parenteral Nutrition industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between leading nutrition companies to enhance product offerings, have been a notable trend. Additionally, mergers and acquisitions, like the acquisition of specialized nutrition providers, have also been observed. Furthermore, product launches, including the introduction of innovative feeding tubes and personalized nutrition solutions, have expanded the market's portfolio. Regulatory changes, such as updates to nutrition guidelines and safety standards, have also impacted the industry. These developments indicate a shift in consumer and enterprise trends towards more personalized and specialized nutrition solutions, with companies investing in funding rounds and expansions to capitalize on these trends.

Analyst Overview

As the Lead Analyst for this study, my expert view is that the Enteral Nutrition and Parenteral Nutrition market outlook is poised for significant growth, driven by an increasing demand for nutrition therapies. The market attractiveness is high, with a growing patient base and an expanding product portfolio. Competitive intensity is moderate, with key players investing in research and development to stay ahead.

The long-term outlook is positive, with an innovation landscape that is constantly evolving to address the needs of patients. The demand-supply balance is expected to be stable, with key players working to meet the growing demand. However, key risk factors such as regulatory changes and supply chain disruptions need to be closely monitored.

11 items

1. Executive Summary

2. Enteral Nutrition and Parenteral Nutrition Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Enteral Nutrition and Parenteral Nutrition Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Enteral Nutrition and Parenteral Nutrition Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital Clinic

6.1.2. Pharmacy

6.1.3. Others

6.2. Global Enteral Nutrition and Parenteral Nutrition Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Oral/Tube Feeding

6.2.2. Intravenous Injection

6.3. Global Enteral Nutrition and Parenteral Nutrition Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Enteral Nutrition and Parenteral Nutrition Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Enteral Nutrition and Parenteral Nutrition Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Enteral Nutrition and Parenteral Nutrition Market Competition by Key Manufacturers

8.1. Global Enteral Nutrition and Parenteral Nutrition Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Enteral Nutrition and Parenteral Nutrition: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. B. Braun

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Baxter

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. BBCA Pharmaceutical

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Biokin Pharmaceutical

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. China Meheco Kangli

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Cisen

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Danone

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Fresenius Kabi

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Grand Life Sciences

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Haisco Pharmaceutical Group

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. JW Pharmaceutical

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Kelun Pharma

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. King York

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Lionco Pharmaceutical

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Lummy

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Medisan

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Medtrition

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Nestlé S.A.

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Otsuka Pharmaceutical

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. Pfizer

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Teva Pharmaceutical

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

9.23. Xi'an Libang Pharmaceutical

9.23.1. Company Basic Information and Sales Area

9.23.2. Main Business/Business Overview

9.23.3. Product Portfolio

9.23.4. Financial

9.23.5. Recent Industry Insights

9.23.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Enteral Nutrition and Parenteral Nutrition Market

Figure 4: Global Enteral Nutrition and Parenteral Nutrition Market: Drivers

Figure 5: Global Enteral Nutrition and Parenteral Nutrition Market: Challenges

Figure 6: Global Enteral Nutrition and Parenteral Nutrition Market: Trends

Figure 7: Global Enteral Nutrition and Parenteral Nutrition Market: Opportunity

Figure 8: Global Enteral Nutrition and Parenteral Nutrition Market: Restraint

Figure 9: Global Enteral Nutrition and Parenteral Nutrition Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Enteral Nutrition and Parenteral Nutrition Market Value (USD Million) By Region

Figure 15: Global Enteral Nutrition and Parenteral Nutrition Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Enteral Nutrition and Parenteral Nutrition Market Value (USD Million) By Region

Figure 23: Global Enteral Nutrition and Parenteral Nutrition Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

99 items

Table 1: Market Segmentation Analysis

Table 2: Global Enteral Nutrition and Parenteral Nutrition Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Enteral Nutrition and Parenteral Nutrition Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Enteral Nutrition and Parenteral Nutrition Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Enteral Nutrition and Parenteral Nutrition Market Value (USD Million) By Region

Table 10: Global Enteral Nutrition and Parenteral Nutrition Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Enteral Nutrition and Parenteral Nutrition Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Enteral Nutrition and Parenteral Nutrition Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Enteral Nutrition and Parenteral Nutrition Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Basic Information And Sales Area

Table 31: Abbott. Products Portfolio

Table 32: B. Braun Basic Information And Sales Area

Table 33: B. Braun. Products Portfolio

Table 34: Baxter Basic Information And Sales Area

Table 35: Baxter. Products Portfolio

Table 36: BBCA Pharmaceutical Basic Information And Sales Area

Table 37: BBCA Pharmaceutical. Products Portfolio

Table 38: Biokin Pharmaceutical Basic Information And Sales Area

Table 39: Biokin Pharmaceutical. Products Portfolio

Table 40: China Meheco Kangli Basic Information And Sales Area

Table 41: China Meheco Kangli. Products Portfolio

Table 42: Cisen Basic Information And Sales Area

Table 43: Cisen. Products Portfolio

Table 44: Danone Basic Information And Sales Area

Table 45: Danone. Products Portfolio

Table 46: Fresenius Kabi Basic Information And Sales Area

Table 47: Fresenius Kabi. Products Portfolio

Table 48: Grand Life Sciences Basic Information And Sales Area

Table 49: Grand Life Sciences. Products Portfolio

Table 50: Haisco Pharmaceutical Group Basic Information And Sales Area

Table 51: Haisco Pharmaceutical Group. Products Portfolio

Table 52: JW Pharmaceutical Basic Information And Sales Area

Table 53: JW Pharmaceutical. Products Portfolio

Table 54: Kelun Pharma Basic Information And Sales Area

Table 55: Kelun Pharma. Products Portfolio

Table 56: King York Basic Information And Sales Area

Table 57: King York. Products Portfolio

Table 58: Lionco Pharmaceutical Basic Information And Sales Area

Table 59: Lionco Pharmaceutical. Products Portfolio

Table 60: Lummy Basic Information And Sales Area

Table 61: Lummy. Products Portfolio

Table 62: Medisan Basic Information And Sales Area

Table 63: Medisan. Products Portfolio

Table 64: Medtrition Basic Information And Sales Area

Table 65: Medtrition. Products Portfolio

Table 66: Nestlé S.A. Basic Information And Sales Area

Table 67: Nestlé S.A.. Products Portfolio

Table 68: Otsuka Pharmaceutical Basic Information And Sales Area

Table 69: Otsuka Pharmaceutical. Products Portfolio

Table 70: Pfizer Basic Information And Sales Area

Table 71: Pfizer. Products Portfolio

Table 72: Teva Pharmaceutical Basic Information And Sales Area

Table 73: Teva Pharmaceutical. Products Portfolio

Table 74: Xi'an Libang Pharmaceutical Basic Information And Sales Area

Table 75: Xi'an Libang Pharmaceutical. Products Portfolio

Table 76: Global Market Value (USD Million) (2025-2032) By Application

Table 77: Global Market Share (%) By Application (2032)

Table 78: Global Market Value (USD Million) (2025-2032) By Types

Table 79: Global Market Share (%) By Types (2032)

Table 80: Global Enteral Nutrition and Parenteral Nutrition Market Value (USD Million) By Region

Table 81: Global Enteral Nutrition and Parenteral Nutrition Market Share (%) By Region (2025-2032)

Table 82: North America Market Value (USD Million) (2025-2032) By Country

Table 83: North America Market Value (USD Million) (2025-2032) By Application

Table 84: North America Market Value (USD Million) (2025-2032) By Types

Table 85: Europe Market Value (USD Million) (2025-2032) By Country

Table 86: Europe Market Value (USD Million) (2025-2032) By Application

Table 87: Europe Market Value (USD Million) (2025-2032) By Types

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 91: South America Market Value (USD Million) (2025-2032) By Country

Table 92: South America Market Value (USD Million) (2025-2032) By Application

Table 93: South America Market Value (USD Million) (2025-2032) By Types

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 97: Research Programs/Design For This Report

Table 98: Key Data Information From Secondary Sources

Table 99: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Enteral Nutrition and Parenteral Nutrition Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.00 billion
Revenue forecast in 2033	21.88 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; B. Braun; Baxter; BBCA Pharmaceutical; Biokin Pharmaceutical; China Meheco Kangli; Cisen; Danone; Fresenius Kabi; Grand Life Sciences; Haisco Pharmaceutical Group; JW Pharmaceutical; Kelun Pharma; King York; Lionco Pharmaceutical; Lummy; Medisan; Medtrition; Nestlé S.A.; Otsuka Pharmaceutical; Pfizer; Teva Pharmaceutical; Xi'an Libang Pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Stringent regulatory requirements and high production costs are limiting the entry of new players in the Enteral Nutrition and Parenteral Nutrition market, which may hinder the growth forecast.

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Enteral Nutrition and Parenteral Nutrition Segmentation Breakdown7 items

Application

Hospital Clinic

Pharmacy

Others

Types

Oral/Tube Feeding

Intravenous Injection

Regional Insights

Loading chart…

Competitive Landscape

Abbott: regional expansion

B. Braun: premium pricing

Baxter: innovation pipeline

Fresenius Kabi: local manufacturing

Nestlé S.A.: OEM tie-ups

Pfizer: vertical integration

Key Enteral Nutrition and Parenteral Nutrition Companies23 items

Abbott

B. Braun

Baxter

BBCA Pharmaceutical

Biokin Pharmaceutical

China Meheco Kangli

Cisen

Danone

Fresenius Kabi

Grand Life Sciences

Haisco Pharmaceutical Group

JW Pharmaceutical

Kelun Pharma

King York

Lionco Pharmaceutical

Lummy

Medisan

Medtrition

Nestlé S.A.

Otsuka Pharmaceutical

Pfizer

Teva Pharmaceutical

Xi'an Libang Pharmaceutical

Market Ecosystem

Raw material suppliers — provide nutritional components

OEMs/manufacturers — produce enteral and parenteral nutrition products

Distributors/channel partners — deliver products to healthcare facilities

Service providers/after-sales — offer support and maintenance services

End users/buyers — healthcare providers and patients

Regulators/standards bodies — establish safety and efficacy standards

Data/analytics providers — provide insights on nutrition therapy outcomes

Recent Industry Insights

Analyst Overview

Table of Contents